Home
EN / FR

Celyad Oncology

Home / Investors / Shareholders Information

Shareholders Information

Shareholders Information

Equity Threshold (as of July 30, 2021)

Equity threshold_73021

Voting Threshold (as of July 30, 2021)

voting threshold_073021

Total Number of Shares And Voting Rights

Total amount of share capital (EUR) (as of July 30th, 2021) 54,956,224.33
Total number of shares with single voting rights (as of July 30th, 2021) 13,425,931
Total number of shares with double voting rights (as of July 30th, 2021) 2,368,025
Total number of shares (as of July 30th, 2021) 15,793,956
Total number of voting rights (as of July 30th, 2021) 18,161,981
Total number of attributed warrants (as of July 30th, 2021) 1,922,423
Total number of shares with voting rights that could be created following the exercise of the attributed warrants (as of July 30th, 2021) 1,922,423
Total number of diluted shares (outstanding shares + warrants) (as of July 30th, 2021) 17,716,379
Total number of diluted shares with voting rights (as of July 30th, 2021) 20,084,404

Transparency Declarations

19 May 2021 Victory Capital Management Inc.
05 May 2021 Tolefi SA
28 Sep 2018 Victory Capital Management Inc.
01 Jun 2018 Tolefi SA
17 Feb 2017 Tolefi SA
03 Aug 2016 Medisun International Ltd and National Fund Ltd
29 Jun 2015 PMV-TINA
29 Jun 2015 SRIW SA
05 Mar 2015 Tolefi SA
20 Aug 2014 Tolefi SA
12 Jul 2013 Tolefi SA, PMV NV, SRIW SA/ Sofipole SA, Mayo Foundation

Investor Contact Information:

Sara Zelkovic

Communications and IR Director

Investors@celyad.com